Praxis Precision Medicines Inc's Company Valuation
Currency: USD Updated: 2026-07-31
Previous score
9.49
Change
0
The current valuation score of Praxis Precision Medicines Inc is 9.49, ranking 15 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -22.99, which is -99.33% below the recent high of -0.15 and -16.02% above the recent low of -26.67.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.